$58.02
+0 (+0%)
At Close: Jun 01, 2026
RAPT Therapeutics Announces Upcoming Oral Presentation of RPT193 Phase 1b Data at the 4th Inflammatory Skin Disease Summit
08:00am, Monday, 18'th Oct 2021
SOUTH SAN FRANCISCO, Calif., Oct. 18, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing
SOUTH SAN FRANCISCO, Calif., Sept. 30, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing
RAPT Therapeutics to Present at Upcoming Investor Conferences
08:00am, Friday, 03'rd Sep 2021
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing
SOUTH SAN FRANCISCO, Calif., June 18, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing
RAPT Reports Positive Data From Atopic Dermatitis Study
12:47pm, Wednesday, 16'th Jun 2021
RAPT up on positive data from an early-stage study in patients with moderate-to-severe atopic dermatitis.
RAPT Therapeutics Announces Pricing of Public Offering of Common Stock
11:07pm, Tuesday, 15'th Jun 2021
SOUTH SAN FRANCISCO, Calif., June 15, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing
RAPT Stock Is Rising, but Don't Call It a Meme Stock
02:07pm, Tuesday, 15'th Jun 2021
RAPT Therapeutics stock more than doubled on Monday. No, that doesn't make it a meme stock.
RAPT Therapeutics (RAPT) is in Overbought Territory: What's Next?
09:46am, Tuesday, 15'th Jun 2021
RAPT Therapeutics (RAPT) has moved higher as of late, but there could definitely be trouble on the horizon for this company
RAPT Stock Price Increased 115.51%: Why It Happened
05:24am, Tuesday, 15'th Jun 2021
The stock price of Rapt Therapeutics Inc (NASDAQ: RAPT) increased by 115.51% yesterday. This is why it happened.
RAPT Therapeutics Announces Proposed Public Offering of Common Stock
04:01pm, Monday, 14'th Jun 2021
SOUTH SAN FRANCISCO, Calif., June 14, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing
Why RAPT Therapeutics Stock Is Surging Today
01:34pm, Monday, 14'th Jun 2021
RAPT Therapeutics Inc (NASDAQ:RAPT) shares are trading higher by 95% at $36.19 after the company reported topline results from its randomized placebo-controlled Phase 1b clinical trial of RPT193 as m
RAPT Stock: The Big Study News That Has RAPT Therapeutics Rocketing 100%+
12:29pm, Monday, 14'th Jun 2021
RAPT Therapeutics (RAPT) stock is rocketing higher on Monday thanks to positive results from a recent clinical trial of RPT193. The post RAPT Stock: The Big Study News That Has RAPT Therapeutics Rocke
RAPT Stock Price Increases Over 80%: Why It Happened
11:14am, Monday, 14'th Jun 2021
The stock price of Rapt Therapeutics Inc (NASDAQ: RAPT) increased by over 80% during intraday trading. This is why it happened.
RAPT Therapeutics to Report Top Line Data from Phase 1b Trial of RPT193 in Atopic Dermatitis
04:00pm, Sunday, 13'th Jun 2021
SOUTH SAN FRANCISCO, Calif., June 13, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing
RAPT Therapeutics to Present at the UBS Global Healthcare Virtual Conference
04:00pm, Thursday, 20'th May 2021
SOUTH SAN FRANCISCO, Calif., May 20, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing a
Sign In
Buy RAPT